Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 180 participants.
Also called NCT07032311
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- SIPPA Solutions INC
- Registry
-
NCT07032311
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07032311. Randomized; no masking; primary purpose treatment. Start 2026-08-20 (anticipated); primary completion 2027-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk
- Acronym
- SIPPA-QH_HHC-2
- Condition
- Type 2 Diabetes
- Condition
- Liver Disease
- Intervention (Device)
- Behavioral Treatment
- Lead sponsor
- SIPPA Solutions INC
- Collaborator
- New York City Health and Hospitals Corporation
Record details
- Record id
cardio:ct-nct07032311- Content hash
ae77dcfcb159d36dfa6d4c6517d29d7bd54491162d454bb5058e1c4f7b82940b